Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Determination of NAT2 acetylation status in the Greenlandic population

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Authors' Reply to Santos et al.: "Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered"

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Midazolam Pharmacokinetics in Obese and Non-obese Children and Adolescents

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A Tablet App Supporting Self-Management for People With Dementia: Explorative Study of Adoption and Use Patterns

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Obesity-induced CYP2E1 activity in children

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Nicolas Quesnot
  • Simon Bucher
  • Christina Gade
  • Manuel Vlach
  • Elise Vene
  • Samuel Valença
  • Thomas Gicquel
  • Helle Holst
  • Marie-Anne Robin
  • Pascal Loyer
View graph of relations

CYP2E1 activity is measured in vitro and in vivo via hydroxylation of the Chlorzoxazone (CHZ) producing the 6-hydroxychlorzoxazone (OH-CHZ) further metabolized as a glucuronide excreted in urine. Thus, the quantification of the OH-CHZ following enzymatic hydrolysis of CHZ-derived glucuronide appears to be a reliable assay to measure the CYP2E1 activity without direct detection of this glucuronide. However, OH-CHZ hydrolyzed from urinary glucuronide accounts for less than 80% of the CHZ administrated dose in humans leading to postulate the production of other unidentified metabolites. Moreover, the Uridine 5'-diphospho-glucuronosyltransferase (UGT) involved in the hepatic glucuronidation of OH-CHZ has not yet been identified. In this study, we used recombinant HepG2 cells expressing CYP2E1, metabolically competent HepaRG cells, primary hepatocytes and precision-cut human liver slices to identify metabolites of CHZ (300 μM) by high pressure liquid chromatography-UV and liquid-chromatography-mass spectrometry analyses. Herein, we report the detection of the CHZ-O-glucuronide (CHZ-O-Glc) derived from OH-CHZ in culture media but also in mouse and human urine and we identified a novel CHZ metabolite, the CHZ-N-glucuronide (CHZ-N-Glc), which is resistant to enzymatic hydrolysis and produced independently of CHZ hydroxylation by CYP2E1. Moreover, we demonstrate that UGT1A1, 1A6 and 1A9 proteins catalyze the synthesis of CHZ-O-Glc while CHZ-N-Glc is produced by UGT1A9 specifically. Together, we demonstrated that hydrolysis of CHZ-O-Glc is required to reliably quantify CYP2E1 activity because of the rapid transformation of OH-CHZ into CHZ-O-Glc and identified the CHZ-N-Glc produced independently of the CYP2E1 activity. Our results also raise the questions of the contribution of CHZ-N-Glc in the overall CHZ metabolism and of the quantification of CHZ glucuronides in vitro and in vivo for measuring UGT1A activities.

Original languageEnglish
JournalArchives of Toxicology
Volume92
Issue number10
Pages (from-to)3077-3091
Number of pages15
ISSN0340-5761
DOIs
Publication statusPublished - Oct 2018

ID: 55622315